| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Revenue | $18.8B (+9.6% YoY) | $21.0B (+6.7% YoY) | Deceleration to +6.7% from +9.6% |
| Net Income Attributable | Not specified | Up 31% YoY Q4 | Strong 31% growth acceleration |
| Diluted EPS (Adjusted) | +42% YoY Q3 | +29% YoY Q4 | Deceleration from +42% to +29% |
| Adjusted EBITDA | Strong Q3 growth | +11% YoY Q4 | Solid double-digit growth maintained |
| Same Facility Admissions | +2.4% YoY Q3 | +2.4% YoY full year | Consistent with long-term range |
| Operating Cash Flow | $4.4B Q3 | $12.6B full year (+20%) | Strong 20% annual growth |
| Hurricane Markets EBITDA | Expected $100M recovery 2025 | $0 growth expected 2026 | Recovery stalling completely |
| Supplemental Payments Net Benefit | $240M Q3 increase | $420M full year, declining $250-450M in 2026 | Major headwind emerging |
| Contract Labor % of SWB | 4.2% Q3 | 4.2% Q4 | Stabilized at manageable level |
| Capital Expenditures | ~$5B guidance 2025 | $5-5.5B guidance 2026 | Increased investment range |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.